8. Introduction: Navigating Treatment Options & Decisions • Dr. Andrew Hendifar & Mary Donlevy

In this segment from the Neuroendocrine Cancer Foundation’s 2026 Virtual Annual Patient Conference, Lisa Yen is joined by co-moderators Mary Donlevy and Dr. Andrew Hendifar to introduce the next section of the program: Navigating Treatment Options and Decisions. This conversation highlights the expanding neuroendocrine cancer treatment landscape, including somatostatin analogs, chemotherapy, PRRT, targeted therapies, liver-directed therapies, and clinical trials. Dr. Hendifar explains how clinicians approach treatment choices by considering tumor burden, whether disease is liver-dominant or present outside the liver, and the role of the neuroendocrine tumor care team. Mary Donlevy shares practical advice for patients who may feel overwhelmed by complex treatment information, including taking notes, tracking symptoms and questions, communicating with the care team before appointments, and staying connected to life beyond cancer. The segment also introduces upcoming presentations on SSAs and chemotherapy, targeted therapies and PRRT, clinical trials, treatment sequencing, treatment side effects, and a panel discussion on navigating treatment decisions. Learn more about the Neuroendocrine Cancer Foundation and access patient resources at www.NCF.net.

Иконка канала NEN_Cancer_hack
10 подписчиков
12+
3 просмотра
4 дня назад
12+
3 просмотра
4 дня назад

In this segment from the Neuroendocrine Cancer Foundation’s 2026 Virtual Annual Patient Conference, Lisa Yen is joined by co-moderators Mary Donlevy and Dr. Andrew Hendifar to introduce the next section of the program: Navigating Treatment Options and Decisions. This conversation highlights the expanding neuroendocrine cancer treatment landscape, including somatostatin analogs, chemotherapy, PRRT, targeted therapies, liver-directed therapies, and clinical trials. Dr. Hendifar explains how clinicians approach treatment choices by considering tumor burden, whether disease is liver-dominant or present outside the liver, and the role of the neuroendocrine tumor care team. Mary Donlevy shares practical advice for patients who may feel overwhelmed by complex treatment information, including taking notes, tracking symptoms and questions, communicating with the care team before appointments, and staying connected to life beyond cancer. The segment also introduces upcoming presentations on SSAs and chemotherapy, targeted therapies and PRRT, clinical trials, treatment sequencing, treatment side effects, and a panel discussion on navigating treatment decisions. Learn more about the Neuroendocrine Cancer Foundation and access patient resources at www.NCF.net.